Evidence map›Paper›PMID 36837799›Full record

ArticleMetabolites2023

The Influence of Probiotic Supplementation on the Severity of Anxiety and Depressive Symptoms; Function and Composition of Gut Microbiota; and Metabolic, Inflammation, and Oxidative Stress Markers in Patients with Depression-A Study Protocol.

Anna Skowrońska, Oliwia Gawlik-Kotelnicka, Aleksandra Margulska, Dominik Strzelecki

Abstract read
In one paragraph

Article in Metabolites, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Efavirenz-Altered Gut-Microbiota,International journal of molecular sciences · 2026
    Article
  2. Review
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Anna SkowrońskaDepartment of Affective and Psychotic Disorders, Central Teaching Hospital, Medical University of Łódź, ul. Czechosłowacka 8/10, 92-216 Łódź, Poland.
Oliwia Gawlik-KotelnickaDepartment of Affective and Psychotic Disorders, Central Teaching Hospital, Medical University of Łódź, ul. Czechosłowacka 8/10, 92-216 Łódź, Poland.ORCID 0000-0003-1398-3117
Aleksandra MargulskaDepartment of Adolescent Psychiatry, Central Teaching Hospital, Medical University of Łódź, ul. Czechosłowacka 8/10, 92-216 Łódź, Poland.
Dominik StrzeleckiDepartment of Affective and Psychotic Disorders, Central Teaching Hospital, Medical University of Łódź, ul. Czechosłowacka 8/10, 92-216 Łódź, Poland.ORCID 0000-0002-8559-1078

Funding

Uniwersytet Medyczny w Lodzi 502-03/1-155-02/502-14-386-18
6 · The paper itself

Abstract

This article aims to present the theoretical basis, methodology, and design of a clinical trial we will conduct. The study will be prospective, randomized, placebo-controlled, and double-blind. Each intervention period will last 8 weeks and the trial will be conducted on 100 patients in total, who will be randomly divided into two groups consisting of 50 patients each. We plan to investigate the impact of

Indexed as

anxiety disordersdepressionmetabolismmicrobiome

Identifiers

PMID36837799
PMCPMC9966580

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.